LAG3 and neoplasm: In addition to tumor antigen selection, tumor-infiltrating lymphocytes and CAR T cells have been shown to become progressively dysfunctional over time and upregulate various inhibitory receptors including PD-1 and lymphocyte-activation gene 3,108 making them ineffective to overcome the potently immunosuppressive TME.